Swiss National Bank’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-153,700
| Closed | -$524K | – | 2451 |
|
|
2024
Q3 | $524K | Hold |
153,700
| – | – | ﹤0.01% | 2427 |
|
|
2024
Q2 | $718K | Buy |
153,700
+8,900
| +6% | +$50.2K | ﹤0.01% | 2311 |
|
|
2024
Q1 | $1.07M | Hold |
144,800
| – | – | ﹤0.01% | 2186 |
|
|
2023
Q4 | $1.47M | Sell |
144,800
-34,400
| -19% | -$302K | ﹤0.01% | 2022 |
|
|
2023
Q3 | $1.4M | Buy |
179,200
+1,900
| +1% | +$16.3K | ﹤0.01% | 2057 |
|
|
2023
Q2 | $1.46M | Buy |
177,300
+28,900
| +19% | +$252K | ﹤0.01% | 2092 |
|
|
2023
Q1 | $1.08M | Sell |
148,400
-17,600
| -11% | -$156K | ﹤0.01% | 2213 |
|
|
2022
Q4 | $1.47M | Buy |
166,000
+4,300
| +3% | +$47.2K | ﹤0.01% | 2088 |
|
|
2022
Q3 | $1.98M | Hold |
161,700
| – | – | ﹤0.01% | 1877 |
|
|
2022
Q2 | $1.91M | Hold |
161,700
| – | – | ﹤0.01% | 1947 |
|
|
2022
Q1 | $3.08M | Buy |
161,700
+11,900
| +8% | +$221K | ﹤0.01% | 1765 |
|
|
2021
Q4 | $3.98M | Hold |
149,800
| – | – | ﹤0.01% | 1617 |
|
|
2021
Q3 | $6.15M | Buy |
149,800
+1,300
| +0.9% | +$71.2K | ﹤0.01% | 1314 |
|
|
2021
Q2 | $8.41M | Buy |
148,500
+6,100
| +4% | +$225K | 0.01% | 1125 |
|
|
2021
Q1 | $5.98M | Buy |
142,400
+1,600
| +1% | +$91.2K | ﹤0.01% | 1342 |
|
|
2020
Q4 | $9.87M | Buy |
140,800
+2,600
| +2% | +$107K | 0.01% | 941 |
|
|
2020
Q3 | $3.88M | Buy |
138,200
+1,700
| +1% | +$55.4K | ﹤0.01% | 1337 |
|
|
2020
Q2 | $4.04M | Buy |
136,500
+47,000
| +53% | +$1.23M | ﹤0.01% | 1272 |
|
|
2020
Q1 | $1.77M | Buy |
89,500
+4,200
| +5% | +$106K | ﹤0.01% | 1523 |
|
|
2019
Q4 | $2.53M | Buy |
85,300
+2,200
| +3% | +$54.9K | ﹤0.01% | 1585 |
|
|
2019
Q3 | $1.89M | Buy |
83,100
+3,100
| +4% | +$76.8K | ﹤0.01% | 1693 |
|
|
2019
Q2 | $1.98M | Buy |
80,000
+14,600
| +22% | +$349K | ﹤0.01% | 1697 |
|
|
2019
Q1 | $1.6M | Buy |
65,400
+2,200
| +3% | +$49.8K | ﹤0.01% | 1800 |
|
|
2018
Q4 | $1.44M | Buy |
63,200
+1,400
| +2% | +$38.1K | ﹤0.01% | 1780 |
|
|
2018
Q3 | $1.97M | Buy |
61,800
+2,600
| +4% | +$84K | ﹤0.01% | 1727 |
|
|
2018
Q2 | $2.12M | Buy |
59,200
+14,400
| +32% | +$510K | ﹤0.01% | 1669 |
|
|
2018
Q1 | $1.49M | Hold |
44,800
| – | – | ﹤0.01% | 1831 |
|
|
2017
Q4 | $1.38M | Buy |
44,800
+4,700
| +12% | +$118K | ﹤0.01% | 1892 |
|
|
2017
Q3 | $963K | Hold |
40,100
| – | – | ﹤0.01% | 2083 |
|
|
2017
Q2 | $673K | Hold |
40,100
| – | – | ﹤0.01% | 2299 |
|
|
2017
Q1 | $895K | Buy |
40,100
+10,000
| +33% | +$207K | ﹤0.01% | 2099 |
|
|
2016
Q4 | $489K | Buy |
30,100
+20,200
| +204% | +$307K | ﹤0.01% | 2405 |
|
|
2016
Q3 | $133K | Hold |
9,900
| – | – | ﹤0.01% | 2528 |
|
|
2016
Q2 | $242K | Buy |
+9,900
| New | +$334K | ﹤0.01% | 2544 |
|
Other funds holding EDIT
Swiss National Bank's EDIT Position: Q4 2024 in Review
Swiss National Bank sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 153,700 shares — an estimated $524K sold.
Swiss National Bank first reported a position in EDIT in Q2 2016 and held it in 34 quarters. The position peaked at $9.87M in Q4 2020. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.
- Swiss National Bank reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
- Swiss National Bank sold 153,700 Editas Medicine shares in Q4 2024, an estimated $524K.
- Swiss National Bank first reported a position in Editas Medicine in Q2 2016 and held it in 34 quarters.
- Swiss National Bank's Editas Medicine position peaked at $9.87M in Q4 2020.
- 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.
Based on Swiss National Bank's 13F filing for Q4 2024, filed 10 Feb 2025.